Study to examine the efficacy of modified treat and extend regimen of aflibercept to branch retinal vein occlusion with cystoid macular edema - Modified treat and extend regimen of aflibercept to branch retinal vein occlusion with cystoid macular edema

Jichi Medical University0 sites50 target enrollmentOctober 27, 2016

Conditionsbranch retinal vein occlusion

Overview

Phase: 未知
Intervention: Not specified
Conditions: branch retinal vein occlusion
Sponsor: Jichi Medical University
Enrollment: 50
Status: Completed
Last Updated: 2 years ago

Overview Investigators Eligibility Criteria Outcomes Similar Trials

Overview

Brief Summary

Arai Y, Takahashi H, Inoda S, Sakamoto S, Tan X, Inoue Y, Tominaga S, Kawashima H, Yanagi Y. Efficacy of Modified Treat-and-Extend Aflibercept Regimen for Macular Edema Due to Branch Retinal Vein Occlusion: 1-Year Prospective Study. J Clin Med 2020 Arai Y, Takahashi H, Inoda S, Sakamoto S, Tan X, Inoue Y, Tominaga S, Kawashima H, Yanagi Y. Efficacy of Modified Treat-and-Extend Regimen of Aflibercept for Macular Edema from Branch Retinal Vein Occlusion:2-Year Prospective Study Outcomes. J Clin Med 2021

Registry

who.int

Start Date

October 27, 2016

End Date

September 30, 2020

Last Updated

2 years ago

Study Type

Interventional

Sex

All

Investigators

Sponsor

Jichi Medical University

Eligibility Criteria

Inclusion Criteria

Not provided

Exclusion Criteria

•Target eye: Prior treatment with anti\-VEGF drug and steroid drug Prior treatment with intraocular surgery (\<3 months) Another diseases to decrease visual acuity Prior treatment with vitrectomy Fellow eye is already enrolled in the study (If already both eyes onset, the eye which has wider occlusion area is enrolled.) Prior history of brain cardiovascular evebts Patient who the doctor in charge judges are ineligible for the study